Date | Time | Source | Headline | Symbol | Company |
01/13/2011 | 12:00PM | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS ANNOUNCES DELISTING FROM THE NASDAQ STOCK MARKET AND TRANSFER TO OTCQB™ MARKETPLACE | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
01/12/2011 | 3:00PM | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Agreement with Consenting Noteholders to Extend Certain Deadlines under Support Agreem | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
01/06/2011 | 5:26PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
01/06/2011 | 4:48PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
01/05/2011 | 8:00PM | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS ANNOUNCES NOTICE OF DELISTING FROM THE NASDAQ STOCK MARKET | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
12/23/2010 | 11:49AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
12/22/2010 | 2:30PM | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Agreement to Extend Cure Period Under Subordinated Note Indenture | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
12/17/2010 | 4:48PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
12/17/2010 | 12:00PM | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Agreement with Consenting Noteholders to Extend Certain Deadlines under Support Agreem | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
12/02/2010 | 5:20PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
12/02/2010 | 12:18PM | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Preliminary Injunction Ruling In Connection With Rex Medical L.P. Litigation | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
12/02/2010 | 12:00PM | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Agreement with Consenting Noteholders to Extend Certain Deadlines under Support Agreem | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
11/29/2010 | 12:30PM | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS ANNOUNCES PRIVATE LABEL PRODUCT SUPPLY AGREEMENT WITH HOLOGIC | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
11/24/2010 | 2:15PM | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Commencement of Proceedings by Rex Medical LP | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
11/16/2010 | 5:08PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
11/09/2010 | 4:35PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
11/09/2010 | 2:42PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
11/09/2010 | 5:00AM | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2010 | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
11/02/2010 | 6:04AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
10/29/2010 | 8:00PM | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Releases Selected Projected Financial Information | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
10/29/2010 | 8:00PM | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces a Strongly Supported Transaction Agreement with Majority of Senior Subordinated Noteho | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
10/13/2010 | 7:00PM | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS ANNOUNCES CONFERENCE CALL AND WEBCAST | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
10/06/2010 | 2:57PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
10/06/2010 | 8:00AM | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Announces Commencement of Arbitration and Litigation Proceedings by QSR Holdings, Inc. Against t | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
10/01/2010 | 8:00AM | PR Newswire (US) | Angiotech Pharmaceuticals, Inc. Defers Interest Payments Under Senior Subordinated Notes. Angiotech Conducting Discussions With | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
09/24/2010 | 11:30AM | PR Newswire (US) | ANGIOTECH ANNOUNCES THAT COOK MEDICAL'S ZILVER(R) PTX(R) DRUG-ELUTING STENT MEETS ITS PRIMARY ENDPOINT IN A 479-PATIENT, MULTI-C | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
09/23/2010 | 2:30PM | PR Newswire (US) | ANGIOTECH PHARMACEUTICALS AND PARTNER ATHERSYS ANNOUNCE UPDATED RESULTS FROM PHASE I STUDY OF MULTISTEM(R) IN HEART ATTACK PATIE | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
09/22/2010 | 2:45PM | PR Newswire (US) | ANGIOTECH ANNOUNCES STRONG OUTCOMES IN DIABETIC PATIENTS TREATED WITH BOSTON SCIENTIFIC CORPORATION'S PLATINUM CHROMIUM TAXUS(R) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
09/22/2010 | 2:45PM | PR Newswire (US) | ANGIOTECH ANNOUNCES LONG-TERM DATA SHOW ADVANTAGES FOR TAXUS(R) LIBERTÉ(R) STENT IN SMALL VESSELS AND LONG LESIONS | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |
08/09/2010 | 4:40PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ANPI | Angiotech Pharmaceuticals - Common Shares (MM) |